Literature DB >> 23742992

The case for Zostavax vaccination in systemic lupus erythematosus.

Abigail R Cogman1, Eliza F Chakravarty.   

Abstract

Entities:  

Keywords:  Autoimmune diseases; Herpes zoster; Infection; Shingles; Systemic lupus erythematosus; Vaccine; Varicella zoster virus

Mesh：

Substances：

Year:  2013        PMID： 23742992      PMCID： PMC3952213          DOI： 10.1016/j.vaccine.2013.05.085

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  30 in total

Review 1.  Treatment of herpes zoster.

Authors:  Wim Opstelten; Just Eekhof; Arie Knuistingh Neven; Theo Verheij
Journal:  Can Fam Physician       Date:  2008-03       Impact factor: 3.275

2.  Herpes zoster in Japanese patients with systemic lupus erythematosus.

Authors:  O Ishikawa; M Abe; Y Miyachi
Journal:  Clin Exp Dermatol       Date:  1999-07       Impact factor: 3.470

3.  Susceptibility of Oka varicella vaccine strain to antiviral drugs.

Authors:  K Shiraki; S Matsui; N Aiba
Journal:  Vaccine       Date:  1993-11       Impact factor: 3.641

4.  A prospective study of the herpes zoster severity of illness.

Authors:  Mélanie Drolet; Marc Brisson; Myron J Levin; Kenneth E Schmader; Michael N Oxman; Robert W Johnson; Stéphanie Camden; James A Mansi
Journal:  Clin J Pain       Date:  2010-10       Impact factor: 3.442

5.  High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis.

Authors:  K Nagasawa; Y Yamauchi; Y Tada; T Kusaba; Y Niho; H Yoshikawa
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

6.  Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.

Authors:  Jie Zhang; Fenglong Xie; Elizabeth Delzell; Lang Chen; Kevin L Winthrop; James D Lewis; Kenneth G Saag; John W Baddley; Jeffrey R Curtis
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

Review 7.  Zoster vaccine: current status and future prospects.

Authors:  Michael N Oxman
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

8.  Herpes zoster in patients with systemic lupus erythematosus.

Authors:  H M Moutsopoulos; J D Gallagher; J L Decker; A D Steinberg
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

9.  Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.

Authors:  L E Kahl
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

10.  Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus.

Authors:  B L Strom; M M Reidenberg; S West; E S Snyder; B Freundlich; P D Stolley
Journal:  Am J Epidemiol       Date:  1994-10-01       Impact factor: 4.897
View more
  2 in total

1.  Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study.

Authors:  Shin-Yi Tsai; Cheng-Li Lin; Ying-Chi Wong; Tse-Yen Yang; Chien-Feng Kuo; Jiung-Mou Cheng; Jyh-Seng Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 2.  Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases.

Authors:  Ahmad AlEnizi; Khaled AlSaeid; Adel Alawadhi; Eiman Hasan; Entesar H Husain; Ahmad AlFadhli; Aqeel Ghanem; Fatemah Abutiban; Yaser Ali; Adeeba Al-Herz; Khuloud Mohammed; Waleed Alkandari; Ali Aldei; Hebah Alhajeri; Ahmad Dehrab; Sawsan Hayat
Journal:  Int J Rheumatol       Date:  2018-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.